FSTL3 and COVID-19: A follow-up to this study was able to reproduce the prior finding and demonstrated that activin A and its pathway marker, FLRG (follistatin-like related gene, also called FLSTL3), were demonstrably elevated in the sera of non-COVID-19 ARDS patients (5).